欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/1001/002
药品名称Gliclazide Medreg
活性成分
    • gliclazide 60.0 mg
剂型Prolonged-release tablet
上市许可持有人Medreg s.r.o. Krčmářovská 223/33 Prague 196 00 Czech Republic
参考成员国 - 产品名称Czechia (CZ)
Gliclazide Medreg
互认成员国 - 产品名称
    • Romania (RO)
      Gliclazide Medreg 60 mg Comprimate cu eliberare prelungită
    • Slovakia (SK)
    • Poland (PL)
许可日期2022/06/02
最近更新日期2024/08/19
药物ATC编码
    • A10BB09 gliclazide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase